BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36680258)

  • 1. Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas.
    Nilson R; Krutzke L; Wienen F; Rojewski M; Zeplin PH; Funk W; Schrezenmeier H; Kochanek S; Kritzinger A
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduction Enhancers Enable Efficient Human Adenovirus Type 5-Mediated Gene Transfer into Human Multipotent Mesenchymal Stromal Cells.
    Nilson R; Lübbers O; Weiß L; Singh K; Scharffetter-Kochanek K; Rojewski M; Schrezenmeier H; Zeplin PH; Funk W; Krutzke L; Kochanek S; Kritzinger A
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34204818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration.
    Na Y; Nam JP; Hong J; Oh E; Shin HC; Kim HS; Kim SW; Yun CO
    J Control Release; 2019 Jul; 305():75-88. PubMed ID: 31071373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells.
    Nilson R; Lübbers O; Schmidt CQ; Rojewski M; Zeplin PH; Funk W; Schrezenmeier H; Kritzinger A; Kochanek S; Krutzke L
    Mol Ther Methods Clin Dev; 2022 Jun; 25():96-110. PubMed ID: 35402633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Transformation of Primary Human Mesenchymal Stromal Cells by Adenovirus Early Region 1 Oncogenes.
    Speiseder T; Hofmann-Sieber H; Rodríguez E; Schellenberg A; Akyüz N; Dierlamm J; Spruss T; Lange C; Dobner T
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D3-inducible mesenchymal stem cell-based delivery of conditionally replicating adenoviruses effectively targets renal cell carcinoma and inhibits tumor growth.
    Hsiao WC; Sung SY; Liao CH; Wu HC; Hsieh CL
    Mol Pharm; 2012 May; 9(5):1396-408. PubMed ID: 22480282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic effect of Midkine promoter-based conditionally replicating adenoviruses expressing EGFR siRNA in head and neck squamous cancer cell line T891.
    Uehara N; Otsuki N; Kubo M; Kitamoto J; Kojima Y; Teshima M; Shinomiya H; Shirakawa T; Nibu KI
    Cancer Rep (Hoboken); 2020 Jun; 3(3):e1231. PubMed ID: 32671980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affilin-based retargeting of adenoviral vectors to the epidermal growth factor receptor.
    Wienen F; Nilson R; Allmendinger E; Graumann D; Fiedler E; Bosse-Doenecke E; Kochanek S; Krutzke L
    Biomater Adv; 2023 Jan; 144():213208. PubMed ID: 36442453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures.
    Dias JD; Guse K; Nokisalmi P; Eriksson M; Chen DT; Diaconu I; Tenhunen M; Liikanen I; Grénman R; Savontaus M; Pesonen S; Cerullo V; Hemminki A
    Eur J Cancer; 2010 Feb; 46(3):625-35. PubMed ID: 20006487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma.
    Rühle A; Lies M; Strack M; Perez RL; Bieber B; Thomsen AR; Bronsert P; Huber PE; Hess J; Knopf A; Wuchter P; Grosu AL; Nicolay NH
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas.
    LaRocca CJ; Han J; Salzwedel AO; Davydova J; Herzberg MC; Gopalakrishnan R; Yamamoto M
    Oral Oncol; 2016 May; 56():25-31. PubMed ID: 27086483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differentiation of hMSCs counteracts their migration capability and pro-angiogenic effects in vitro.
    Scherzed A; Hackenberg S; Froelich K; Rak K; Schendzielorz P; Gehrke T; Hagen R; Kleinsasser N
    Oncol Rep; 2016 Jan; 35(1):219-26. PubMed ID: 26530463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.
    Muhammad T; Sakhawat A; Khan AA; Ma L; Gjerset RA; Huang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):190. PubMed ID: 31238944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
    Tysome JR; Wang P; Alusi G; Briat A; Gangeswaran R; Wang J; Bhakta V; Fodor I; Lemoine NR; Wang Y
    Hum Gene Ther; 2011 Sep; 22(9):1101-8. PubMed ID: 21361787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates.
    Bots STF; Kemp V; Cramer SJ; van den Wollenberg DJM; Hornsveld M; Lamfers MLM; van der Pluijm G; Hoeben RC
    Hum Gene Ther; 2022 Mar; 33(5-6):275-289. PubMed ID: 34861769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck squamous cancer cells enhance the differentiation of human mesenchymal stem cells to adipogenic and osteogenic linages
    Meyer TJ; Hackenberg S; Herrmann M; Gehrke T; Steber M; Hagen R; Kleinsasser N; Scherzad A
    Oncol Lett; 2022 Dec; 24(6):450. PubMed ID: 36420071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer.
    Hamada M; Yura Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A replication-selective adenoviral vector for head and neck cancers.
    Tanaka H; Shirakawa T; Zhang Z; Hamada K; Gotoh A; Nibu K
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):630-4. PubMed ID: 16027288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
    Shimizu Y; Gumin J; Gao F; Hossain A; Shpall EJ; Kondo A; Parker Kerrigan BC; Yang J; Ledbetter D; Fueyo J; Gomez-Manzano C; Lang FF
    J Neurosurg; 2022 Mar; 136(3):757-767. PubMed ID: 34450587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.
    Rudy SF; Brenner JC; Harris JL; Liu J; Che J; Scott MV; Owen JH; Komarck CM; Graham MP; Bellile EL; Bradford CR; Prince ME; Carey TE
    J Otolaryngol Head Neck Surg; 2016 Apr; 45():26. PubMed ID: 27117272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.